Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo.
about
Phase I study of intravenous PSC-833 and doxorubicin: reversal of multidrug resistance.Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitorsThe co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression.Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation.Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.Apoptotic sphingolipid ceramide in cancer therapy.Dynamic assessment of mitoxantrone resistance and modulation of multidrug resistance by valspodar (PSC833) in multidrug resistance human cancer cells.Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents.Proteomic analysis of an imatinib-resistant K562 cell line highlights opposing roles of heat shock cognate 70 and heat shock 70 proteins in resistance.Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy.Determination of intracellular organelles implicated in daunorubicin cytoplasmic sequestration in multidrug-resistant MCF-7 cells using fluorescence microscopy image analysis.Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein.PDMP blocks brefeldin A-induced retrograde membrane transport from golgi to ER: evidence for involvement of calcium homeostasis and dissociation from sphingolipid metabolism.Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine.Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.In vivo model systems in P-glycoprotein-mediated multidrug resistance.Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918.Initial pharmacokinetics and bioavailability of PSC 833, a P-glycoprotein antagonist.Pharmacokinetics of PSC 833 (valspodar) in its Cremophor EL formulation in rat.Valspodar: current status and perspectives.Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties.The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: clinical course and in vivo model.Inhibition of P-glycoprotein by cyclosporin A analogues and metabolites.Modulation of multidrug resistance by SDZ PSC 833 in leukemic and solid-tumor-bearing mouse models.
P2860
Q32063216-E2B895AC-81E2-4130-8102-1384CFA342C8Q33864976-5B6C6CB0-7FA1-435E-BF8C-4990F19523C9Q33961526-9F7DE6D1-3D4C-42B3-8079-1B8D06E4C7ADQ34303346-7734ED2F-DA9B-4790-93AB-B420A9E24F07Q34450507-6B8A2FBA-38AC-4C92-8BF9-0C7F5BEA6D32Q34736760-87FE3670-39E8-466D-9015-28C082F8733AQ37267975-0CD92CC4-4E6E-41D2-9E51-09684740574AQ38005689-96E7E174-B6FE-4D86-9FF3-1C0EB97C07B4Q39970911-916373FC-32B4-4A34-9F75-AED4EAFC0077Q40781139-862379F9-5A97-4531-91B3-C3E1B8E0AF66Q40902740-1D417665-B2D5-4D92-9F50-056FB457F2F8Q40978951-7FB331EF-D4F5-4D9A-AD99-E12480DC3670Q41026275-ADFAEE7E-F35C-4171-A3DE-F16CD386D55AQ41611878-18EE0AF5-FEAF-4210-A81F-97C193F28995Q41681702-F7168539-E8FC-49B1-A826-0F27DA344C53Q41734226-F006BCCC-D592-4454-A74D-CD32436AA068Q42029087-2D435B84-3CAD-4ACC-B9A8-E74BD2B67E99Q42651277-CB9E0766-7023-4449-BC77-4D5A05C79DCBQ43244972-0C1B3264-CB3A-41C2-8772-55B1ECA451C6Q48826637-1BE73B6F-603D-4A0B-85F0-9B0D082069C3Q50672428-6AAC84C7-0D1D-411F-8571-9A6B6DA4E8C4Q53956744-E6466EA1-12B4-420F-A28B-DA5983B67D88Q54084308-6C9896C2-89A5-41CD-80EC-195ACC0C9861Q55043110-3C37C8D7-7D0D-46BE-B1CB-B0E10B6D87BA
P2860
Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Comparative study on reversal ...... sistance in vitro and in vivo.
@en
Comparative study on reversal ...... sistance in vitro and in vivo.
@nl
type
label
Comparative study on reversal ...... sistance in vitro and in vivo.
@en
Comparative study on reversal ...... sistance in vitro and in vivo.
@nl
prefLabel
Comparative study on reversal ...... sistance in vitro and in vivo.
@en
Comparative study on reversal ...... sistance in vitro and in vivo.
@nl
P2093
P2860
P1433
P1476
Comparative study on reversal ...... sistance in vitro and in vivo.
@en
P2093
P2860
P304
P356
10.3109/02841869509093961
P577
1995-01-01T00:00:00Z